These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7083728)

  • 1. Sotalol prolongation of the QTc interval in hypertensive patients.
    Neuvonen PJ; Elonen E; Tanskanen A; Tuomilehto J
    Clin Pharmacol Ther; 1982 Jul; 32(1):25-32. PubMed ID: 7083728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic changes after long-term treatment with sotalol in hypertensive patients.
    Castro M; Descamps R; Thomis JA
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):88-91. PubMed ID: 7061183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction over time of QTc prolongation in patients with sotalol after cardioversion of atrial fibrillation.
    Lenhoff H; Darpö B; Ferber G; Rosenqvist M; Frick M
    Heart Rhythm; 2016 Mar; 13(3):661-8. PubMed ID: 26654918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
    Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
    Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not-in-trial simulation I: Bridging cardiovascular risk from clinical trials to real-life conditions.
    Chain AS; Dieleman JP; van Noord C; Hofman A; Stricker BH; Danhof M; Sturkenboom MC; Della Pasqua O
    Br J Clin Pharmacol; 2013 Dec; 76(6):964-72. PubMed ID: 23617533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide.
    Garabelli P; Stavrakis S; Albert M; Koomson E; Parwani P; Chohan J; Smith L; Albert D; Xie R; Xie Q; Reynolds D; Po S
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):827-32. PubMed ID: 27027653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in cardiac repolarization following intravenous sotalol administration.
    Somberg JC; Preston RA; Ranade V; Cvetanovic I; Molnar J
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):86-92. PubMed ID: 21527783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects].
    Rehm KD; Schnelle K; Dyde CJ; Blümner E; Arendts W
    Arzneimittelforschung; 1987 Sep; 37(9):1058-62. PubMed ID: 3435602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotalol, hypokalaemia, syncope, and torsade de pointes.
    McKibbin JK; Pocock WA; Barlow JB; Millar RN; Obel IW
    Br Heart J; 1984 Feb; 51(2):157-62. PubMed ID: 6197982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
    Cobbe SM; Alexopoulos D; Winner SJ; McCaie CP; Cobbe PC; Johnston J
    Eur Heart J; 1988 Jan; 9(1):24-31. PubMed ID: 2450026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of sotalol-induced maximum steady-state QTc prolongation from single-dose administration in healthy volunteers.
    Le Coz F; Funck-Brentano C; Poirier JM; Kibleur Y; Mazoit FX; Jaillon P
    Clin Pharmacol Ther; 1992 Oct; 52(4):417-26. PubMed ID: 1424415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of hypertension with single daily doses of sotalol hydrochloride.
    Gabriel R
    Curr Med Res Opin; 1976-1977; 4(10):739-42. PubMed ID: 1052165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and women.
    Funck-Brentano C; Salem JE
    Br J Clin Pharmacol; 2022 Jul; 88(7):3510-3515. PubMed ID: 34921433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sotalol on ambulatory electrocardiography in volunteers.
    Kantelip JP; Trolese JF; Cadilhac M; Pechadre JC; Duchêne-Marullaz P
    Clin Pharmacol Ther; 1986 Nov; 40(5):554-60. PubMed ID: 3769386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.
    Barbey JT; Sale ME; Woosley RL; Shi J; Melikian AP; Hinderling PH
    Clin Pharmacol Ther; 1999 Jul; 66(1):91-9. PubMed ID: 10430114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic effects of sotalol and propranolol on ventricular repolarization using constant-rate pacing.
    Creamer JE; Nathan AW; Shennan A; Camm AJ
    Am J Cardiol; 1986 May; 57(13):1092-6. PubMed ID: 3518383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog.
    Gomoll AW; Lekich RF; Bartek MJ; Comereski CR; Antonaccio MJ
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):204-11. PubMed ID: 1697375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.